Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Innova Captab Limited ( (IN:INNOVACAP) ) has shared an announcement.
Innova Captab Limited announced that its manufacturing facility in Jammu & Kashmir has successfully passed an inspection by the State Service of Ukraine on Medicines and Drugs Control, leading to a recommendation for a GMP compliance certificate. This certification, under the Pharmaceutical Inspection Co-operation Scheme, is expected to enhance the facility’s global credibility and facilitate access to regulated markets, strengthening the company’s international positioning.
More about Innova Captab Limited
Innova Captab Limited operates in the pharmaceutical industry, focusing on the manufacturing of medicinal products. The company is based in India and aims to enhance its market presence by adhering to international compliance standards.
Average Trading Volume: 2,172
Technical Sentiment Signal: Hold
For detailed information about INNOVACAP stock, go to TipRanks’ Stock Analysis page.

